EntryPoint Capital’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,216
Closed -$259K 1108
2024
Q1
$259K Buy
14,216
+496
+4% +$9.05K 0.23% 48
2023
Q4
$150K Buy
+13,720
New +$150K 0.14% 190